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Abstract
Eke, Ransome, MD, Ph.D. The University of Memphis. May 2015.
Depression and Benign Prostatic Hyperplasia in elderly male Medicare
Beneficiaries. Major Professor: Xinhua Yu, MD, Ph.D.
Depression is a common cause of disability and mortality in the elderly
population. Benign prostatic hyperplasia (BPH), a benign enlargement of prostate
gland, may be related to depression in men, as reported in previous studies. This
dissertation explored the co-occurrence of depression and BPH in elderly men, the
transition probabilities of depression status as its relations to varying BPH
transition status, and the effect of socioeconomic disadvantage on depression in
men with BPH. The data were drawn from the Medicare Current Beneficiary
Survey (MCBS) and Medicare claims data from 2005 through 2009. The study
population comprised of community dwelling elderly male Medicare beneficiaries
aged 65 years or above (N=10, 067). Depression and BPH were defined using both
self-report and diagnostic codes. Two transition processes for depression and BPH
were constructed based on two follow-up years. The Markov process for depression
and BPH states progression and their probabilities were determined. The transition
rates were assessed using generalized linear mixed models with covariance matrix
estimated by generalized estimating equations to explain the variations between
repeated measures. Survey weights and multilevel cluster effect was considered in
all our analysis. We adjusted for age, race, marital status, education level, income
levels, insurance coverage, and comorbidities including cancer, diabetes, heart
diseases, arthritis, and other mental health conditions. We found an overall
prevalence of 13% for depression and about 41% for BPH. The adjusted risk ratio
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(ARR) of depression in men with BPH compared with no BPH was 1.16 (95% CI,
1.04-1.30). Compared to those who remained with no-BPH, there was about 50%
more chances of transiting from depression to no depression state in men who
progressed from BPH to no-BPH status, (Adjusted transition rate, 1.49; 95% CI,
1.05-2.12;p-values= 0.021). The probability of transition from no-depression to
depression in elderly men with two or more comorbidity was about two-folds
higher compared with no comorbidity. Heterogeneity in socioeconomic context is a
significant determinant of depression risk in elderly men with BPH. In conclusion,
a significant impact of BPH on depression was reported. There is need to sensitize
healthcare professionals on the importance of carefully depression evaluation
among elderly men.
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CHAPTER 1
INTRODUCTION
Background
Depression in late life, defined as having depressive symptoms in adults aged 65
or older, is a severe and common mental health condition in the elderly population
(American Psychiatric Associations Diagnostic and Statistical Manual (DSM-IV)) [1-4].
In the United States, nearly 7 million of the 31 million elderly over 65 years are affected
by depressive symptoms [5]. About 10–12% of the medically ill older adult suffers from
major depression [6]. However, depression is often under-diagnosed or undertreated in
primary care settings [7, 8]. The World Health Organization (WHO) reports that
symptoms of depression in older people are commonly overlooked or untreated because
they coincide with other late life medical conditions [8]. Meanwhile, under-recognition of
depression in late life can lead to worse outcomes of preexisting medical illnesses, other
emotional sufferings, quality of life and risk of disability [9-11]. For example, elderly
people with depression have other chronic medical conditions such as diabetes, arthritis,
cardiovascular diseases and cancer, as well as neurological conditions like dementia
and/or Alzheimer’s disease, all of which are generally referred to comorbidities [12-16].
Of these comorbidities, benign prostatic hyperplasia (BPH) may be a significant cause of
morbidity and emotional suffering in elderly men and negatively affect health quality of
life of aging men, which may lead to depressive symptoms [17-20]. A recent report
showed an improvement in recognizing depression among the nursing homes residents
[21]. Nevertheless, the association of aging with multiple chronic medical conditions has
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led to missed opportunities for early detection of depressive illness in the primary care
settings [22-29].
Epidemiology of depression
Depression is a mood disorder, characterized by feeling of sadness and
diminished interest in life [15, 30]. It is also associated with abnormal physical and other
mental changes such as weight gain or loss, psychomotor agitation or retardation, fatigue,
inappropriate guilt, concentration difficulties, as well as recurrent thoughts of death [31].
Older people with depression typically report more symptoms of physical weakness and
insomnia than other age groups [15, 32, 33].
The prevalence of depression among the elder population varies among studies,
regions, and dwelling status [4, 33-39], ranging from 10 to 15% per year in the US
elderly population [40-46]. A report from the Aging, Demographic and Memory study
(ADAMS), drawn from Health and Retirement Study, estimated the overall prevalence of
depression in the general older population at 11.2%, and about 10.2% among elderly men
[46]. The National Health and Nutrition Examination Survey (NHANES) conducted from
2007 to 2010, estimated the prevalence of current depression in males aged 60 years or
above at approximately 5% [47]. This does not contradict the above US prevalence as
NHANES measures the point prevalence of depression among community dwellers.
However, studies conducted among elderly Australians reported a significantly lower
prevalence of 2- 8%, partly due to different tools used in assessing depression symptoms
[48, 49].
Compared with community dwellers, the risk of depression among older
population living in institutional facilities such as nursing homes and long-term care
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facilities is about two folds higher [4, 15, 44, 49-56]. Studies have argued that coexisting
psychiatric illnesses is the predominant cause of high risk of depression among those in
the institutional settings [1, 4, 48, 51, 57-59]. Although reports have shown that older
individuals underutilize mental health facilities [60-63], depression is significantly
associated with increased healthcare services utilization among adult population [2, 6466]. Egede and colleagues have shown that the coexistence of major depression with
common chronic medical conditions is associated with significantly greater odds of
ambulatory care visits, emergency department visits, days spent in bed due to illness and
functional disability [67, 68].
Risk factors for depression in the elderly
Depression in the elderly results from complex interactions among individual,
environmental and genetic predisposing factors. Individual and environmental factors are
the leading determinants of depression in the elderly [69]. Factors that influence
depression among the elderly can be generally classified into: (1) Socioeconomic status
such as race/ethnicity, marital status, education, income level, and residence; (2) Medical
conditions such as chronic diseases, mental health illnesses and organic brain diseases
(e.g. cognitive impairment and Alzheimer’s disease); (3) Adverse life events such as loss
of job and bereavement, and (4) Family history of depression [69-74].
Depression prevalence varies across race and socioeconomic groups [75-78]. The
risk of depression is higher in White (11.7%) and Hispanic (12.5%) elderly population
compared to Blacks (4%) [46]. Further, there is a higher prevalence of depression in older
people residing in urban locations compared to those in the rural locations [75-78].
Studies also suggest that uninsured or underinsured elderly people are at higher risk of
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depression. For instance, studies have found that underinsured Medicare beneficiaries
were undertreated for depression because of partial coverage and high copay for mental
health treatment [64, 79-82].
Studies have consistently demonstrated that depression is frequent among elderly
people with chronic diseases such as diabetes, cancer, arthritis, cardiovascular disease
and chronic obstructive pulmonary disease (COPD) [83-91]. When people age, these
chronic diseases occur, partly due to aging process and also due to cumulative effects of
different risk exposures. Even though depression is not a process of aging, advanced age
has been linked with a higher risk of depression, which may be explained by their high
susceptibility to chronic medical conditions, physical disability and cognitive decline [4,
78, 92].
Epidemiology of benign prostatic hyperplasia
BPH is a non-cancerous enlargement of the prostate gland associated with aging
in men [93-96]. It is the major cause of lower urinary symptoms (LUTS) in men [97101]. Although BPH is a slowly progressing disease, detection rate has increased in aging
men because of the growing awareness of prostate cancer screening [100, 102]. The
prevalence of BPH among men over 65 years ranges from 20% to 60% [102-106].
Common symptoms of LUTS include increased bladder outlet obstruction, urinary
frequency, urgency, hesitancy, incomplete emptying, weak urinary stream and frequent
urination at night [107-111]. These symptoms can negatively affect the quality of life of
aging men with BPH [101, 105, 110, 112, 113]. Despite that much research has been
done about BPH, the pathophysiologic mechanism of BPH is still unclear. Some
mechanisms have been linked to stimulation of growth of the prostate gland in aging
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men. The immune-inflammatory pathway may promote prostate tissue growth through
activation of growth factors [114-121]. In addition, the action of the active metabolite of
testosterone hormone (e.g., dihydrotestosterone, DHT) following hormonal alteration has
been reported in the older men [122, 123]. While the level of overall testosterone reduces
in aging in men, the DHT and the androgen receptor (AR) levels remain relatively high
[124].
Co-occurrence of depression and benign prostatic hyperplasia in aging men
Studies that explored the relation between depression and BPH in aging men are
scarce. Up till now, only six articles have explored this association in the general male
population, which include five cross sectional studies and one retrospective cohort study
[108, 125-129]. These studies suggest a consistent and significant increased risk of
depression among elderly people with BPH or LUTS. One study also demonstrated that
compared with Blacks, the odds of depressive symptoms was high among White men
with LUTS (OR 2.60, 95% CI 1.39–4.85, p <0.01), and Hispanic men with LUTS (OR
4.14, 95% CI 1.15–14.95, p <0.05) [127]. Still, the mechanism between depression and
BPH is unclear. A common inflammatory pathway may play a role in this relationship
[108].
However, methodological concerns and limited adjustment for confounding
factors raise issues regarding the interpretation of these findings. For instance, Huang et
al., 2011, drew their sample from mostly outpatient population (ambulatory care visits),
therefore there may have been a possible surveillance bias among patients with BPH
[125] and the study did not control for confounding effect of coexisting medical
conditions. The remaining studies comprised of men below the ages 65 years [108, 125,
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129, 130]. Only two studies, conducted in the same population of elderly Chinese men,
limited their analysis to older individuals with age 65 years or above [126, 128]. One
study was conducted in a clinical setting [108].
The most common instruments used to define BPH/LUTS in these studies were
American Urological Association Symptom Index (AUA-SI) or the International Prostate
Symptom score (IPSS) instrument [108, 125, 126, 128-130]. The AUA Symptom Index
(identical to the seven symptom questions of the International Prostate Symptom Score)
is used for early assessment of patients suspected with BPH symptoms [131]. The AUASI scores are categorized as having mild (score 0 to 7), moderate (8 to 19), and severe (20
to 35) LUTS. Overall, watchful waiting strategy is the standard management for patients
suspected of having early BPH [104, 110, 132, 133].
On the contrary, the instruments used to measure depression varied across studies.
They include the Geriatric depression scale (GDS), Center for Epidemiologic Studies
Depression Scale (a validated questionnaire from the Massachusetts Male Aging Study),
the NHANES Patient Health Questionnaire-9 (PHQ-9), and International Classification
of Diseases Ninth Edition (ICD-9) diagnostic codes [108, 125, 126, 128-130]. These
instruments may vary in their sensitivity and specificity, thus influence the finding
observed in the different studies.
Other methodological issues also exist. For example, the retrospective study by
Huang et al., 2011, that examined the induction time for depression in men with BPH had
some methodological limitations because information of censored participants had been
omitted [125]. Furthermore, by stratifying the analysis by age group, their study had low
power to detect significant effect because of the small sample size [134].
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In spite of the methodological issues, previous studies provide a framework and
foundation to better examine the association between BPH and depression in aging men.
A thorough understanding of the burden of depression and the transition of depression
status with BPH health states in elderly men is important to elucidate the causal sequence
between BPH and depression. Therefore, it is beneficial to conduct a study using a more
rigorous technique to explore this relationship. We propose to use data from a nationally
representative population with diverse socio-demographic and models controlling for
factors known to influence the occurrence of depression in elderly population.
Study Rationale
Increasing life expectancy results in a growing elderly population in both the US
and around the world. Consequently, there is a significant rise in the burden of depression
and chronic medical conditions. Under-detection and under treatment of depression may
lead to disability and poor quality of life in older people. There is a gap in our
understanding of how BPH might influence risk of depression in older male population.
In addition, it is not well understood whether BPH is a sufficient cause to increase the
risk of depression or a combined effect of BPH with other comorbidities or
socioeconomic context. No previous study has examined the transition probabilities
between depression and BPH states in elderly men. To examine the transition states, the
Markov transition model technique is the most appropriate approach and provides
information on the time sequence and causal inference between depression and BPH.
The main objectives of this study are: (1) To describe the epidemiology of
depression and BPH occurrence among elderly male Medicare beneficiaries in the United
States enrolled between years 2005 and 2009. (2) To determine the transition
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probabilities of depression states and their relation to the changes of BPH status in elderly
men during the two years of follow up. (3) To examine the impact of socioeconomic
disadvantages on depression in elderly men with BPH.
Conclusion
A thorough understanding of the burden of depression in elderly male population
is critical and necessary for targeted intervention. The results from this research will
facilitate effective health planning and policy change. Furthermore, understanding the
effect of socioeconomic disadvantage on depression in elderly men with BPH will
address health disparity and allocate limited health resources more efficiently.
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CHAPTER 2
CO-OCCURRENCE OF DEPRESSION AND BENIGN PROSTATIC
HYPERPLASIA IN ELDERLY MEN
Introduction
Depression is a common psychiatric problem with serious consequences in the
elderly population [1, 2, 4, 15, 78, 135]. The prevalence of depression among elderly
community dwellers is approximately 8-15%, with an estimated prevalence of about 10%
in the primary healthcare settings [4, 8, 136-138]. Reports show that depression in the
elderly is often either under-recognized or undertreated [8, 139]. In addition to the aging
process as a predisposing factor, several studies have suggested a significant relationship
between chronic medical conditions and depression among the aging population [3, 13,
15, 140, 141]. For instance, medical conditions such as cardiovascular diseases, diabetes
mellitus, chronic obstructive airway diseases, cancer, and arthritis are associated with an
increased risk of depression occurrence [16, 39, 59, 142-146]. However, Krishan et al,
2002, noted that reverse association may exist between depression and medical
conditions like heart diseases, cancer, arthritis and diabetes [13].
There is limited epidemiologic research on the relation between depression and
benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate, in
elderly men. Findings from recent studies suggest that BPH may be associated with an
increased risk of depression among men [108, 126-129]. However, the mechanism
underlying this relationship is unclear. An inflammatory mechanism may be a possible
common pathway [108]. BPH can cause significant health problems that negatively
impact the quality of life of aging men [86, 102, 119, 148, 149]. It affects between 20 to
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60% of elderly men and commonly presents with distressing lower urinary tract
symptoms (LUTS) [148-151], including poor urinary stream, hesitancy, terminal
dribbling and incomplete voiding. The bothersome LUTS symptoms could be responsible
for the increased risk of depression in this population [20, 152, 153]. Two studies of the
association between LUTS and depression among Chinese men with age of 65 year or
above, found that depression risk was higher among men experiencing LUTS compared
to those with no LUTS [126, 128]. However, this study did not fully capture the influence
of other comorbidities on depression.
The objective of this study is to examine the risk of depression in elderly men
aged 65 years or above with BPH, controlling for effects of comorbidities and other
socio-demographic determinants of depression. The current study analyzes data from the
Medicare Current Beneficiary Survey (MCBS), a national representative sample of US
elderly population, and the accompanying Medicare claims data from 2005 to 2009.
Materials and methods
Data from MCBS and the Medicare claims data from 2005 through 2009 were
combined. The study population comprised of elderly men 65 years or above. The MCBS
is nationally representative study conducted by the Center for Medicare and Medicaid
Services (CMS). The survey participants are recruited every fall to replenish one third of
MCBS sample, thus forming a yearly cohort. They will be followed up for three years.
Every year there will be three rounds of interviews in which extensive questionnaires are
used to solicit information including socioeconomic status, health status, health care
utilization and medication use. We extracted information about depression and BPH
from personal health interviews conducted among elderly men living in the community
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and from the claims data using the International Classification of Disease, version nine
(ICD-9) codes. We used Medicare Part A (inpatients claims), outpatient claims, and Part
B (claims for physicians and other services) from 2005 to 2009 to identify clinical cases
of depression and BPH.
Outcome Measure
Depression: The health status survey questionnaire has two questions related to
depression symptoms. The first question is whether the respondent was sad or depressed
in the past 12 months (“all of the time”, “most of the time”, “some of the time”, “a little
of the time” and “none of the time”). The second question is whether they had loss of
interest in the past 12 months (‘yes” or “no”). We defined depression as follows: (1) Any
respondent who reported having been sad or depressed “all of the time” or “most of the
time”; (2) sad or depressed “some of the time” and also loss of interest, and (3) clinically
diagnosed depression, i.e., having the ICD-9 codes for depression from the claims data.
The ICD-9 codes used to extract unipolar depression, based on prior studies, were 296.2
(major depressive disorder, single episodes), 296.3 (major depressive disorder, recurrent
episodes), 300.4 (neurotic depression), 309.0 (Adjustment disorder with depressed
mood), 309.1 (prolonged depressive reaction), and 311 (depression, not elsewhere
classified). [79] This consolidated definition of depression with the above methods
(claims data and survey questions) enabled us to identify all cases diagnosed clinically
and those probably under-reported depression cases [155]. After crosschecking the cases
of depression between the survey and claims data, we observed that about 6% of elderly
men who reported depression in the survey were not clinically diagnosed while 2% of
people with clinical depression did not report such in the survey

11

Main predictor
Benign prostatic hyperplasia (BPH): We identified BPH cases from responses to
the question on whether “Past year respondent was told he had enlarged prostate/BPH”
(“yes” or “no”). We also identified clinically diagnosed BPH using the ICD-9 codes from
the claims data. The ICD-9 codes according to Urologic disease in America’s
recommendation [101] were: 594.1 (Other calculus in bladder), 599.6 (Urinary
obstruction), 599.60 (Urinary obstruction, unspecified), 600 (hyperplasia of the
prostrate), 788.2 (Retention of urine), and 788.4 (Frequency of urination and polyuria).
Finally, we crosschecked the responses to the questions and physicians diagnosis and
found that 12% of respondent who self-reported BPH where not clinically identified from
the claims data, while 15% of people with confirmed BPH by the physicians did not
report such in the survey.
Covariates
Comorbidities: the health survey provided information on the following medical
conditions: cancer, heart disease, diabetes mellitus, arthritis and mental health illness
excluding depression. Respondents were asked whether in the past year, a doctor ever
told them they had the above diseases or conditions. We categorized the responses as yes
or no to any of the questions. We also created a summary variable called total
comorbidity that is the sum of coexisting medical illness listed above.
Socio-demographic covariates from survey data included and classified: age
group (65 – 69, 70 – 74, 75 – 79, 80 – 84 and 85+), race (White, Black, other), marital
status (Married, Widowed, Divorced/separated, and other), education (Less than high
school, High school, and College certificates or above). Other variables include income
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level (Less than $15,000, $15,001 - $25, 000, and More than $25, 000), and insurance
coverage (Medicare only, Medicare and Employer-Sponsored Insurance (ESI), Medicare
and Self-purchased (SP), and all three types of insurance). Variables that are reported as
refused to answer or with no value were treated as missing values. No additional missing
imputation was employed given the small percentage of missing.
Statistical Analysis
Analysis was restricted to community dwelling elderly men ages 65 years or
above. We excluded the following respondents from our analysis hierarchically: those
with prostate cancer (n=133), and those with end-stage renal failure because of similarity
with symptoms of BPH (n = 5). Descriptive statistics was performed for the overall study
population and stratified by survey year using the SURVEYFREQ procedure in SAS.
Risk ratios were estimated using generalized linear mixed models with covariance matrix
estimated by generalized estimating equations (GEE) to explain the variation between
repeated measures (PROC GENMOD in SAS). We accounted for the complex sampling
design by incorporating the multilevel clusters and weight variables into all analysis. The
final model for the multivariate analyses was selected using the QIC (Quasi-likelihood
under the independence model criterion) analogous to the AIC (Aikaike’s Information
Criterion) statistics used for comparing model fits because the GEE method is not a
likelihood-based method and does not provide the AIC. The smaller QIC statistics is
preferred. QIC fit statistics provides working correlation structure for a given model [156,
157]. We also stratified our analysis by year of survey, number of comorbidities and the
types of comorbidities. Finally, we conducted subset analyses using depression and BPH
information from the claims data only or self-report only to examine effects of
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underreporting. All analyses was done using SAS version 9.4 (SAS Institute Inc., Cary,
NC, USA).
Results
The survey included 10, 067 community dwelling male MCBS participants, aged
65 years or above, from 2005 through 2009. The average age was 76 years, and the
maximum was 101 years. Table 1 shows the summary of respondents’ characteristics.
The prevalence pooled over three years was 13% for depression and about 41% for BPH.
The majority of the participants were Non-Hispanic Whites population (87%) and over
two-thirds of the respondents were currently married. Nearly 44% had college level
certificates and 61% had annual income levels of greater than $25, 000.00. In addition to
Medicare insurance, 64% had other private insurance coverage (Self-Purchased,
Employer-Sponsored or both). Heart diseases (55%) such as congestive heart failure,
heart valve diseases, and myocardial infarction, are the most common medical condition,
followed by cancers (30%) excluding prostate and skin cancer. About 70% of the study
sample had one or more coexisting comorbidities.
Table 2 provides a description of study sample by year of survey. From 2005
through 2009, the annual prevalence of depression was approximately 9% and the annual
prevalence of BPH ranged from 32% to 36%. The proportion of elderly men aged 85
years and above increased from 8.7% in 2005 to 10.4% in 2009. There was no difference
in the proportion of individuals sampled by race during the survey period and over twothird of the surveys were White non-Hispanics. The proportion of elderly men with less
than high school education decreased slightly over time from 26% to 22% while those
with college education increased from 42 to 46% (p-value <.0001). In addition, the
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proportion with income greater than $25, 000.00 increased from 58% in 2005 to 64% in
2009. The prevalence of diabetes mellitus (p-value <.0001) and heart diseases (p-value =
0.2086) increased during the five years and other mental health conditions (excluding
depression) decreased from 9% to about 2% (p-value <.0001) .
Multivariate analysis of the relationship between depression and BPH adjusted for
survey year, age group, race, marital status, education, income, insurance and number of
comorbidities is shown in Table 3. There was a significant increase of the risk of
depression with BPH compared with no BPH (Adjusted risk ratio (ARR), 1.16; 95% CI,
1.04-1.30; p-value = 0.005). Those surveyed in year 2006 and 2007 had significantly
higher risk of depression compared to with 2005 (ARR, 1.20; 95% CI, 1.05-1.36 and
ARR, 1.19; 95%CI, 1.05-1.35, respectively). The results also show that older age groups
over 69 years compared with 65 to 69 years old is associated with significantly higher
risk of depression (Table 3). Widowed and divorced/separated marital status compared
with married were associated with a higher risk of depression (ARR, 1.50; 95% CI, 1.301.73 and ARR, 1.32; 95%CI, 1.09-1.59 respectively), while an education level of high
school or above compared with less than high school, as well as annual income level
more than $25, 000 compared with less than $15,000 were significantly associated with
lower risk of depression. The risk of depression also significantly increased with the
number of comorbidities. No significant difference was found among race and types of
insurance coverage.
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Table 1. Description of study sample of men ages 65 years and greater: Medicare Current
Beneficiary Survey (MCBS), 2005– 2009 pooled.
Variables
Ever depressed in three years
Benign prostatic hyperplasia
Survey year
2005**
2006
2007
2008
2009
Race/Ethnicity
White Non-Hispanics
Black Non-Hispanics
Hispanics
Other
Age in years
65 – 69
70 – 74
75 – 79
80 – 84
85+
Marital status
Married
Widowed
Divorced/separated
Other
Education
Less than high school
High school
College
Income level
Less than $15,000
$15,000 - $25, 000
More than $25, 000
Comorbidity
Diabetes
Arthritis
Cancer
Heart disease
Mental Health

N = 10, 067
1, 432
4, 493

Weighted percentage
13.0
40.6

3, 914
1, 644
1, 716
1, 564
1, 229

33.0
15.9
17.7
17.6
15.7

8, 826
720
213
308

86.9
7.7
2.0
3.5

2, 518
2, 411
1, 878
1, 773
1, 487

35.1
23.5
18.0
13.1
10.3

7, 209
1, 580
939
339

73.2
13.2
9.9
3.8

2, 630
3, 207
4, 230

24.2
31.6
44.3

805
3, 334
5, 928

7.8
31.7
60.5

2, 732
472
3, 218
5, 788
1, 033

27.0
4.1
29.6
54.5
9.5
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Table 1 (continued). Description of study sample of men ages 65 years and greater:
Medicare Current Beneficiary Survey (MCBS), 2005– 2009 pooled.
Variables
N = 10, 067
Weighted percentage
Insurance coverage
Medicare only
3, 572
36.3
ESIa
3, 486
35.2
b
SP
2, 289
21.5
ESI and SPc
720
7.1
No. of interviews
1
4, 129
49.3
2
2, 637
22.9
3
3, 301
27.8
Total Comorbidities
0
2, 790
29.3
1
4, 028
39.8
2 or more
3, 247
31.0
a
Employer Sponsored Insurance (ESI) and Medicare
b
Self-purchased (SP) insurance and Medicare
c
Employer sponsored, self-purchased and Medicare insurance
**2005 has larger sample size because it also includes 2004 cohort.
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Table 2. Description of study sample by year of survey.
Variables
Ever depressed in past year
Benign prostatic hyperplasia
Race/Ethnicity
White Non-Hispanics
Black Non-Hispanics
Hispanics
Other
Age in years
65 – 69
70 – 74
75 – 79
80 – 84
85+
Marital status
Married
Widowed
Divorced/separated
Other
Education
Less than high school
High school
College
Income level
Less than $15,000
$15,000 - $25, 000
More than $25, 000

2005
N = 3, 914
(%)
365 (8.9)
1, 435 (35.0)

2006
N = 3, 897
(%)
387 (9.5)
1, 492 (36.4)

2007
N = 3, 994
(%)
367 (8.8)
1, 527 (36.2)

2008
N = 3, 967
(%)
373 (9.0)
1, 402 (33.4)

2009
N = 3, 240
(%)
300 (9.0)
1, 112 (32.0)

3, 434 (87.5)
292 (7.7)
79 (1.9)
109 (3.0)

3, 428 (87.5)
267 (7.3)
86 (2.0)
116 (3.2)

3, 517 (87.6)
278 (7.4)
94 (2.2)
105 (2.8)

3, 511 (87.3)
261 (7.5)
86 (1.9)
109 (3.3)

2, 854 (87.4)
226 (7.6)
64 (1.7)
96 (3.3)

995 (31.6)
893 (23.6)
834 (21.9)
706 (14.2)
486 (8.7)

963 (31.2)
914 (24.4)
811 (21.1)
717 (14.3)
492 (9.1)

953 (31.4)
945 (25.0)
793 (19.6)
762 (14.3)
541 (9.7)

949 (32.0)
955 (24.6)
760 (18.8)
741 (14.2)
562 (10.4)

822 (33.5)
783 (24.9)
609 (18.3)
556 (12.9)
470 (10.4)

2, 841 (73.9)
627 (13.9)
335 (9.0)
111 (3.3)

2, 826 (73.5)
604 (13.6)
329 (9.0)
138 (4.0)

2, 888 (73.5)
608 (13.2)
371 (9.9)
127 (3.4)

2, 824 (72.5)
637 (14.0)
378 (10.1)
128 (3.5)

2, 313 (72.6)
499 (13.3)
333 (10.9)
95 (3.3)

1, 076 (26.2)
1, 272 (32.3)
1, 566 (41.5)

1, 071 (26.4)
1, 231 (32.1)
1, 595 (41.6)

1, 040 (24.5)
1, 294 (32.6)
1, 660 (42.9)

999 (23.3)
1, 273 (31.8)
1, 695 (44.8)

798 (22.4)
1, 029 (31.4)
1, 413 (46.1)

346 (8.8)
1, 350 (33.1)
2, 218 (58.2)

298 (7.4)
1, 313 (32.7)
2, 286 (60.0)

307 (7.7)
1, 267 (30.5)
2, 420 (61.8)

291 (7.0)
1, 231 (30.2)
2, 445 (62.9)

242 (7.0)
1, 007 (29.7)
1, 991 (64.3)

18

Table 2 (Continued). Description of study sample by year of survey.
2005
N = 3, 914
(%)

2006
N = 3, 897
(%)

Variables
Comorbidity
Diabetes
845 (21.4)
896 (23.1)
Arthritis
104 (2.5)
111 (2.8)
Cancer
1, 144 (27.6) 1, 157 (28.1)
Heart disease
1, 886 (47.8)
1, 932 (48.2)
Mental Health
352 (9.2)
303 (7.8)
Insurance coverage
Medicare only
1, 256 (32.5)
1, 237 (32.4)
a
ESI
1, 348 (34.5)
1, 375 (35.4)
SPb
1, 014 (24.9)
952 (23.5)
c
ESI and SP
296 (8.1)
333 (8.7)
Total Comorbidities
0
1, 141 (30.5)
1, 104 (29.7)
1
1, 603 (40.0)
1, 582 (40.4)
2 or more
1, 170 (29.5)
1, 211 (29.9)
a
Employer Sponsored Insurance (ESI) and Medicare
b
Self-purchased (SP) insurance and Medicare
c
Employer sponsored, self-purchased and Medicare insurance

19

2007
N = 3, 994
(%)

2008
N = 3, 967
(%)

2009
N = 3, 240
(%)

1, 002 (25.3)
105 (2.4)
1, 217 (28.8)
2, 021 (49.2)
331 (8.0)

1, 084 (27.3)
110 (2.5)
1, 208 (28.5)
2, 005 (49.6)
329 (8.0)

923 (28.0)
77 (2.2)
940 (26.8)
1, 663 (50.7)
42 (1.5)

1, 362 (35.0)
1, 401 (35.4)
908 (21.8)
323 (7.8)

1, 427 (36.9)
1, 375 (35.0)
863 (20.7)
302 (7.4)

1, 264 (39.1)
1, 117 (35.4)
658 (19.4)
201 (6.1)

1, 088 (28.7)
1, 566 (39.1)
1, 340 (32.2)

1, 046 (27.8)
1, 556 (39.2)
1, 365 (33.1)

895 (29.0)
1, 310 (40.6)
1, 035 (30.5)

Table 3. Multivariate analysis of determinants of depression in elderly male Medicare
beneficiaries.
Variables
Benign prostatic hyperplasia
No (Ref)
Yes
Survey year
2005 (Ref)
2006
2007
2008
2009
Race/Ethnicity
White Non-Hispanics (Ref)
Black Non-Hispanics
Hispanics
Other
Age in years
65 – 69
70 – 74
75 – 79
80 – 84
85+
Marital status
Married (Ref)
Widowed
Divorced/separated
Other
Education
Less than high school (Ref)
High school
College
Income level
Less than $15,000 (Ref)
$15,000 - $25, 000
More than $25, 000
Insurance coverage
Medicare only (Ref)
ESI
SP
ESI and SP
Total Comorbidities
0 (Ref)
1
2 or more

ARR

95% C.I

p-value

1.16

1.04 – 1.30

0.010

1.20
1.19
1.00
0.84

1.05 – 1.36
1.05 – 1.35
0.86 – 1.16
0.69 – 1.03

0.006
0.007
0.980
0.088

0.88
0.86
1.11

0.70 – 1.10
0.62 – 1.19
0.77 – 1.59

0.264
0.360
0.582

1.19
1.44
1.27
1.37

0.98 – 1.45
1.19 – 1.74
1.02 – 1.58
1.12 – 1.68

0.080
0.001
0.034
0.002

1.50
1.32
1.10

1.30 – 1.73
1.09 – 1.59
0.68 – 1.77

< 0.0001
0.004
0.708

0.78
0.68

0.69 – 0.90
0.59 – 0.79

0.001
< 0.0001

0.96
0.70

0.79 – 1.16
0.57 – 0.85

0.669
0.001

1.02
0.94
0.94

0.90 – 1.15
0.79 – 1.11
0.74 – 1.19

0.802
0.444
0.602

1.31
2.07

1.10 – 1.54
1.74 – 2.46

0.002
< 0.0001
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Multivariate analysis of determinants of depression in elderly Medicare
beneficiaries stratified by number of comorbidities is shown in table 4.The risk of
depression among BPH compared with no BPH was significant among respondents
without any comorbidity (ARR, 1.44; 95% CI, 1.12-1.86). In addition, among those with
two or more comorbidities the risk of depression in those with BPH was about 18%
higher (ARR, 1.18; 95% CI, 1.02- 1.38) compared with no BPH.

Table 4. Multivariate analysis of determinants of depression in elderly Medicare
beneficiaries stratified by number of comorbidities.

Variables
Benign prostatic hyperplasia
No (Ref)
Yes
Survey year
2005 (Ref)
2006
2007
2008
2009
Race/Ethnicity
White Non-Hispanics
Black Non-Hispanics
Hispanics
Other
Age in years
65 – 69 (Ref)
70 – 74
75 – 79
80 – 84
85+

Number of comorbidities
None, n = 2, 790
1, n = 4, 028
>= 2, n = 3, 247
ARR (95% C.I)
ARR (95% C.I)
ARR (95% C.I)
1.44 (1.12 – 1.86)*

0.99 (0.83 – 1.13)

1.18 (1.02 – 1.38)*

1.01 (0.71 – 1.43) 1.42 (1.14 – 1.78)*
1.15 (0.83 – 1.59) 1.42 (1.15 – 1.75)*
1.43 (1.08 – 1.88)* 0.95 (0.73 – 1.25)
0.74 (0.48 – 1.14) 0.97 (0.72 – 1.31)

1.09 (0.91 – 1.31)
1.03 (0.85 – 1.24)
0.84 (0.68 – 1.04)
0.77 (0.57 – 1.03)

1.06 (0.70 – 1.62)
0.85 (0.40 – 1.84)
1.15 (0.47 – 2.81)

0.70 (0.50 – 0.98)*
1.10 (0.67 – 1.78)
1.17 (0.64 – 2.15)

0.99 (0.69 – 1.43)
0.69 (0.45 – 1.08)
1.05 (0.69 – 1.61)

1.41 (0.93 – 2.14) 1.31 (0.99 – 1.73)
1.92 (1.25 – 2.96)* 1.58 (1.18 – 2.10)*
1.36 (0.84 – 2.20) 1.54 (1.11 – 2.13)*
1.92 (1.21 – 3.05)* 1.54 (1.13 – 2.11)*

1.05 (0.80 – 1.39)
1.22 (0.93 – 1.61)
1.08 (0.80 – 1.45)
1.11 (0.83 – 1.50)
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Table 4 (Continued). Multivariate analysis of determinants of depression in elderly Medicare
beneficiaries stratified by number of comorbidities
None, n = 2, 790
ARR (95% C.I)

Number of comorbidities
1, n = 4, 028
>= 2, n = 3, 247
ARR (95% C.I)
ARR (95% C.I)

Variables
Marital status
Married (Ref)
Widowed
1.55 (1.12 – 2.15)* 1.68 (1.32 – 2.14)*
Divorced/separated
1.41 (0.96 – 2.08) 1.40 (1.05 – 1.85)*
Other
0.66 (0.32 – 1.39) 0.77 (0.40 – 1.46)
Education
Less than high school (Ref)
High school
0.77 (0.58 – 1.03) 0.84 (0.68 – 1.04)
College
0.68 (0.49 – 0.96)* 0.67 (0.52 – 0.87)*
Income level
Less than $15,000 (Ref)
$15,000 - $25, 000
0.73 (0.47 – 1.12) 1.08 (0.80 – 1.45)
More than $25, 000
0.59 (0.38 – 0.91)* 0.81 (0.59 – 1.11)
Insurance coverage
Medicare only (Ref)
ESIa
1.04 (0.75 – 1.45) 1.03 (0.83 – 1.27)
SPb
1.20 (0.86 – 1.66) 0.73 (0.58 – 0.93)*
ESI and SPc
0.96 (0.52 – 1.78) 1.12 (0.79 – 1.60)
a
Employer Sponsored Insurance (ESI) and Medicare
b
Self-purchased (SP) insurance and Medicare
c
Employer sponsored, self-purchased and Medicare insurance
*Significant at p –value < 0.05

1.33 (1.08 – 1.65)*
1.18 (0.90 – 1.55 )
1.45 (0.78 – 2.71)
0.74 (0.60 – 0.91)*
0.69 (0.57 – 0.85)*
1.03 (0.76 – 1.36)
0.70 (0.51 – 0.92)*
0.99 (0.82 – 1.20)
1.01 (0.80 – 1.26)
0.81 (0.56 – 1.17)

We stratified our analysis into types of comorbidity strata as shown in table 5. In
particular, the risk of depression due to BPH was substantially higher among those with
cancer (ARR, 1.34; 95% CI, 1.10-1.64) and heart disease (ARR, 1.15; 95% CI, 1.021.31).
Table 6 shows results of our multivariate analysis by survey year. Except for the
year 2006, there was a consistent higher risk of depression men with BPH compared to
those with no BPH, however only year 2008 was significant.
Results from our subset analysis of the association between BPH and depression
based on claims data only showed estimates for the prevalence of depression at 3% and
22

BPH at 22%. In contrast, the prevalence of depression based on survey data was 10% and
for BPH was 26%. The risk of depression was significantly higher among those with
clinically diagnosed BPH compared no BPH (ARR, 1.78; 95% CI, 1.36-2.33). Although,
the risk of self-reported depression was higher among self-reported BPH compared with
no BPH, it was not statistically significant (ARR, 1.06; 95% CI, 0.93-1.21). Another
important observation of the subset analysis was that individuals who had additional
private insurance coverage (such as self-purchased and employer sponsored insurance)
compared to those with Medicare only had a higher risk of clinically diagnosed
depression. On the contrary, the risk of self-reported depression was significantly lower
among those who had additional insurance compared with Medicare only insurance.
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Table 5. Multivariate analysis of determinants of depression in elderly Medicare beneficiaries stratified by type of
comorbidities.

Variables
Benign prostatic hyperplasia
No (Ref)
Yes
Survey year
2005 (Ref)
2006
2007
2008
2009
Race/Ethnicity
White Non-Hispanics (Ref)
Black Non-Hispanics
Hispanics
Other
Age in years
65 – 69 (Ref)
70 – 74
75 – 79
80 – 84
85+

Cancer
ARRa (95% C.I)
n = 3,218

Diabetes
ARR (95% C.I)
n = 2,732

Arthritis
ARR (95% C.I)
n = 472

Heart disease
ARR (95% C.I)
n = 5,788

Mental Health
ARR (95% C.I)
n = 1,033

1.34 (1.10 – 1.63)

1.15 (0.96 – 1.38)

1.28 (0.87 – 1.88)

1.15 (1.02 – 1.31)

1.09 (0.96 – 1.24)

1.24 (0.97 – 1.57)
1.29 (1.05 – 1.59)
1.08 (0.85 – 1.38)
0.94 (0.66 – 1.35)

1.19 (0.93 – 1.52)
1.17 (0.91 – 1.50)
0.97 (0.74 – 1.27)
0.84 (0.58 – 1.21)

1.01 (0.64 – 1.60)
1.21 (0.79 – 1.86)
1.23 (0.73 – 2.09)
1.22 (0.55 – 2.74)

1.23 (1.05 – 1.44)
1.26 (1.07 – 1.47)
0.92 (0.76 – 1.12)
0.91 (0.71 – 1.17)

1.02 (0.86 – 1.21)
1.18 (1.01 – 1.39)
1.01 (0.82 – 1.25)
1.27 (0.80 – 2.02)

1.58 (0.89 – 2.82)
0.65 (0.28 – 1.53)
1.19 (0.62 – 2.29)

0.72 (0.51 – 1.10)
0.69 (0.44 – 1.08)
0.73 (0.42 – 1.24)

0.73 (0.30 – 1.78)
2.08 (1.05 – 4.12)
1.65 (0.79 – 3.47)

0.79 (0.60 – 1.05)
0.84 (0.56 – 1.24)
1.07 (0.73 – 1.56)

1.09 (0.82 – 1.46)
1.12 (0.78 – 1.60)
1.08 (0.68 – 1.72)

1.84 (1.18 – 2.87)
2.14 (1.41 – 3.25)
1.86 (1.19 – 2.90)
2.00 (1.31 – 3.05)

1.10 (0.82 – 1.48)
1.21 (0.90 – 1.65)
1.19 (0.86 – 1.65)
1.07 (0.76 – 1.49)

0.89 (0.52 – 1.53)
0.77 (0.46 – 1.32)
0.77 (0.46 – 1.30)
0.73 (0.40 – 1.33)

1.02 (0.81 – 1.29)
1.24 (0.99 – 1.55)
1.13 (0.88 – 1.44)
1.08 (0.8 – 1.37)

1.13 (0.90 – 1.44)
1.24 (0.99 – 1.55)
1.05 (0.82 – 1.34)
1.16 (0.90 – 1.49)
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Table 5 (Continued). Multivariate analysis of determinants of depression in elderly Medicare beneficiaries stratified by type of
comorbidities
Cancer
ARRa (95% C.I)
n = 3,218

Diabetes
ARR (95% C.I)
n = 2,732

Variables
Marital status
Married (Ref)
Widowed
1.43 (1.17 – 1.76) 1.53 (1.18 – 1.99)
Divorced/separated
1.15 (0.86 – 1.54) 1.38 (1.03 – 1.84)
Other
1.02 (0.59 – 1.78) 1.52 (0.69 – 3.36)
Education
Less than high school (Ref)
High school
0.76 (0.61 – 0.95) 0.77 (0.58 – 1.02)
College
0.58 (0.46 – 0.73) 0.76 (0.60 – 0.98)
Income level
Less than $15,000 (Ref)
$15,000 - $25, 000
0.83 (0.61 – 1.13) 0.89 (0.65 – 1.21)
More than $25, 000
0.57 (0.42 – 0.77) 0.62 (0.44 – 0.88)
Insurance coverage
Medicare only (Ref)
b
ESI
1.07 (0.87 – 1.30) 0.99 (0.78 – 1.26)
SPc
0.92 (0.73 – 1.15) 0.93 (0.72 – 1.22)
d
ESI and SP
0.92 (0.66 – 1.30) 1.19 (0.75 – 1.87)
a
Adjusted risk ratio
b
Employer Sponsored Insurance (ESI) and Medicare
c
Self-purchased (SP) insurance and Medicare
d
Employer sponsored, self-purchased and Medicare insurance
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Arthritis
ARR (95% C.I)
n = 472

Heart disease
ARR (95% C.I)
n = 5,788

Mental Health
ARR (95% C.I)
n = 1,033

1.23 (0.76 – 1.99)
0.83 (0.44 – 1.58)
1.63 (0.64 – 4.17)

1.51 (1.29 – 1.77)
1.24 (0.99 – 1.54)
1.30 (0.71 – 2.39)

1.10 (0.94 – 1.28)
0.99 (0.79 – 1.23)
1.22 (0.85 – 1.76)

0.81 (0.53 – 1.25)
0.78 (0.49 – 1.23)

0.76 (0.64 – 0.90)
0.69 (0.58 – 0.82)

0.97 (0.82 – 1.15)
0.92 (0.79 – 1.06)

1.94 (0.83 – 4.56)
1.32 (0.56 – 3.13)

1.05 (0.83 – 1.33)
0.79 (0.62 – 1.01)

1.17 (0.90 – 1.51)
1.04 (0.79 – 1.38)

1.19 (0.72 – 1.96)
1.24 (0.77 – 2.00)
1.12 (0.47 – 2.87)

1.01 (0.86 – 1.19)
0.93 (0.71 – 1.13)
0.88 (0.65 – 1.19)

0.99 (0.84 – 1.16)
1.00 (0.83 – 1.20)
0.84 (0.62 – 1.13)

Table 6. Multivariate analysis of determinants of depression in elderly Medicare beneficiaries stratified by survey year.
2005
ARR* (95% C.I)
n = 3,913

2006
ARR* (95% C.I)
n = 3,894

2007
ARR* (95% C.I)
n = 3,994

2008
ARR* (95% C.I)
n = 3,967

2009
ARR* (95% C.I)
n = 3,667

Variable
Benign prostatic hyperplasia
No (Ref)
Yes
1.13 (0.89 – 1.43) 0.88 (0.73 – 1.06) 1.08 (0.86 – 1.36) 1.40 (1.11 – 1.75) 1.18 (0.92 – 1.50)
Total Comorbidities
0 (Ref)
1
1.30 (0.99 – 1.71) 1.36 (0.99 – 1.88) 1.45 (1.02 – 2.07) 1.22 (0.87 – 1.72) 1.53 (1.12 – 2.07)
2 or more
2.37 (1.82 – 3.07) 2.90 (2.18 – 3.87) 3.35 (2.43 – 4.60) 2.42 (1.81 – 3.25) 1.80 (1.32 – 2.45)
*Adjusted relative risk and 95% confidence intervals for the relation between depression and BPH stratified by survey years and adjusted
for age group, race, marital status, education, income level, insurance coverage and number of comorbidities.
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Discussion
Our study used population based longitudinal data of elderly men aged 65 years
or above and were enrolled in the Medicare program from 2005 through 2009, to
examine the co-occurrence of depression and BPH. The present study showed that
depression is a common problem among elderly men 65 years or above in the United
States. Overall, the risk of depression is 16% higher among elderly men with BPH. Even
with possible under-diagnosis of clinical depression in elderly men, there is a significant
relation between clinically diagnosed depression and BPH.
Studies of the relation between depression and BPH in men have generally shown
a significant positive effect of BPH [108, 125, 126, 128, 129]. We also found that the
association of depression in late life and BPH was two folds higher among elderly men
with two or more comorbidities such as heart diseases, diabetes mellitus, and cancers
excluding prostrate and skin cancers. This finding is also consistent with other studies
that have reported significant relations between chronic medical conditions like cancer,
diabetes, and cardiovascular diseases, and depression in the elderly population [3, 4, 12,
48, 158-161]. Notably, our study approach allows us to control for the confounding effect
of these comorbidities on the relation of depression and BPH in the elderly men.
Findings from our study also suggest an increasing proportion of aging elderly
male Medicare beneficiaries, especially those 85 years or above. This supports the reports
about increasing population of the elderly in the US [3, 4, 12, 48, 158-162]. Furthermore,
we found that increasing age is associated with higher risk of depression in men. Aging
process is a predisposing risk for of multiple medical morbidities [141]. The strong
association between depressions with age 85 or above compared to those between ages
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65 and 69, may suggest deteriorating health status and the quality of life of the very old
male population. Other studies suggest that delayed recognition or treatments of
depression are significantly associated with increased morbidity, worsening medical
conditions and poor quality of life among the elderly [141, 163, 164].
The findings from the present study also revealed that socio-demographic factors
including marital status, income level, education level and health insurance coverage
might influence occurrence of depression in this population. A higher risk of depression
was found in elderly widowed and divorced/separated men compared with married men.
The effect of marital status and depression in elderly population has also been reported in
other studies [4, 135, 165-167]. Therefore, strategies to provide an effective social
support system are critical to reduce further disability from depression and to improve the
quality of life among aging men especially for the very old and socially isolated. Our
study also supports the findings from other studies on effect of higher education and
income levels on lower risk of depression [166, 168]. Higher income and education level
probably provides better access to information and affordable health care. One interesting
finding from this study was that the risk of clinically diagnosed depression was higher
among elderly men with Medicare with additional private insurance (such as selfpurchased and employer-sponsored insurance). This suggests that additional insurance
may allow patients visit physicians more often and be diagnosed depression. In contrast,
the risk of self-reported depression is lower in elderly men who have both Medicare plus
additional private insurance compared with Medicare only insurance. This is not
contradicting to the findings for clinical depression because self-report depression refers
to any depressive symptoms of which some are moderate and do not fit for clinical
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diagnosis. It is likely that people with better health insurance will be better taken care of
thus less likely to report depression. These findings may inform further research on
influence of socioeconomic disadvantage and depression in elderly men with BPH.
This study has several strengths. First, it is a community based national
representative sample of US aging men. Second, we considered the effects of significant
comorbidities such as cancer, heart diseases and arthritis in the elderly population. Third
and more importantly, we defined depression and BPH using both clinically defined ICD9 CM codes in the physicians’ claim data and self-report in MCBS health survey data.
This allows us to address depression more accurately. Finally, we considered other
important socio-demographic characteristics associated with depression during our
analysis, which minimizes the effect of confounding by these characteristics. Some of the
study’s limitations include a cross-sectional design when data analyzed by year, so we
could not assess causality. The validity of the instrument used to assess depression is
unknown. Therefore, using the self-report data to define depression might not be reliable.
Conclusion
This study shows that depression is prevalent among elderly male population in
the US. Consistent with other studies, we observed that the prevalence of depression and
benign prostatic hyperplasia (BPH) are high in elderly men. BPH is significantly related
to a higher risk of depression in this population. This risk of depression is further
increased by the presence of other medical conditions like cancer, diabetes mellitus, and
heart diseases. The association is further strengthened between clinically diagnosed
depression and BPH in elderly men. In addition, our results support the importance of
socioeconomic factors such as marital status, education and income levels on the risk of
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depression in the elderly. Therefore, evaluating elderly men with BPH for depression
symptoms in healthcare facilities is critical to reduce further disability and to improve the
quality of life.
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CHAPTER 3
ESTIMATING THE TRANSITION PROBABILITY OF DEPRESSION IN
ELDERLY MEN WITH BENIGN PROSTATIC HYPERPLASIA
Introduction
Benign prostatic hyperplasia (BPH) is a common non-cancerous enlargement of
the prostate gland in aging men. The prevalence ranges from 20% to 60% in men ages 65
years or above [98, 101, 111, 169, 170]. Common lower urinary tract symptoms (LUTS)
include increased urinary frequency, urgency, nocturnal urination, weak urinary stream
and incomplete bladder emptying. The LUTS is a burdensome symptom complex with
significantly negative impact on the quality of life among elderly men [105, 126, 127,
171]. The LUTS worsens over time if no appropriate treatment is provided. While the
management of BPH continues to evolve rapidly, surgical treatments including minimally
invasive surgical treatments, remain the mainstay for preventing disease progression
[110]. Although the risk of BPH is higher with increasing age, the pathological
mechanism of BPH is still not clear. Studies have hypothesized inflammatory process and
hormonal pathways as the most probable mechanisms through which BPH develops [108,
172, 173]. It has been suggested that high levels of active metabolite dihydrotestosterone
(DHT) and androgen receptors (AR) are major hormonal factors [122, 123, 174, 175].
Studies have shown poorer emotional outcomes and decreased quality of life in
elderly men with LUTS [17, 176-178], however, only a few studies have evaluated the
relationship between depression and BPH in aging men. Results from recent studies,
including our previous study, suggest an increased risk of depression in men with BPH
[108, 125-129]. The time order between depression and BPH is not quite understood.
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Huang et al, 2011, employed survival analysis strategy to examine the induction time of
depression in men with BPH. They observed that the risk of depression increased within
one year of developing BPH symptoms [125]. However, the interpretation of this result is
limited due the weakness of the survival analysis in this study. For example, information
about depression and BPH would have been missing as result of censoring participants.
Given the importance of BPH as a risk of late life depression in elderly men, there is a
need to examine how the change of BPH status may influence depression status and to
elucidate the time order of disease progression.
The aim of this study is to evaluate the relationship of different depression and
BPH status in elderly men, using the Markov transition modeling approach. The Markov
transition modeling is a natural model of repeated categorical outcome [179]. It is used
frequently to investigate the natural history of chronic diseases and to predict the longterm benefits of intervention [134, 180-183].
The Markovian transition assumes that patients are always in one of a finite
number of states of health, thus providing a convenient way of modeling prognosis for
clinical problems with ongoing risk change [179, 181, 182, 184, 185]. For the purpose of
our study, we used a longitudinal data drawn from the Medicare Current Beneficiary
Survey (MCBS) and the claims data to examine the transition risk of depression status in
elderly men with different BPH status.
Materials and methods
Study design
Briefly, the Medicare Current Beneficiary Survey (MCBS) is a rotating panel
survey of a national representative sample of Medicare beneficiaries [186]. It provides
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longitudinal data on health status, Medicare utilization, prescription drug use and
expenditures. The current study used longitudinal data collected from interview rounds
37, 40, 43, 46, and 49 of the MCBS during the fall of 2005 through fall of 2009. Sampled
persons who are living in the community will yield longitudinal series of data on the use
of health services, medical care expenditures, health insurance coverage. Our final study
population was elderly men aged 65 years or above who had at least one year follow up
and were free from prostate cancer. We constructed the transition time based on the
follow up years. This study followed 5,807 elderly men from the baseline to the first
follow up year to construct the first transition, and 3,138 subjects from the first follow up
year to the second follow up year as the second transition time.
Outcome measure
Depression: The MCBS has two questions about depression in the survey
questionnaire: (1) if respondent was sad or depressed in the past 12 months (“all of the
time”, “most of the time”, “some of the time”, “a little of the time” and “none of the
time”. (2) If respondent had loss of interest in the past 12 months (‘yes” or “no”). We
defined depression as follows: (1) Any respondent who reported sad or depressed “all of
the time” or “most of the time”; (2) sad or depressed “some of the time” and also loss of
interest. (3) Clinical cases of depression from the Medicare claim’s data using the
International Classification of Disease, ninth edition Clinical Modification (ICD-9-CM)
codes. Depression codes include 296.2 (major depressive disorder, single episodes),
296.3 (major depressive disorder, recurrent episodes), 300.4 (neurotic depression), 309.0
(Adjustment disorder with depressed mood), 309.1 (prolonged depressive reaction), and
311 (depression, not elsewhere classified).
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Independent variable
Respondents with BPH were identified from the response to the MCBS survey
question on whether past year respondent was told he had enlarged prostate/BPH
(“yes”/“no”). The second measure of BPH was from the ICD-9-CM codes reported in
the claims data. The ICD-9-CM codes according to Urologic disease in America’s
recommendation were 594.1 (Other calculus in bladder), 599.6 (Urinary obstruction),
599.60 (Urinary obstruction, unspecified), 600 (hyperplasia of the prostrate), 788.2
(Retention of urine), and 788.4 (Frequency of urination and polyuria) [101]. The two
sources were combined to define BPH in this study.
Covariates
Other information collected includes socio-demographic characteristics (age
group, education, race, income, marital), insurance coverage and medical condition such
as heart diseases, arthritis, diabetes mellitus, mental health conditions and cancer
(excluding skin cancer). Comorbidities were categorized as yes or no based on the
response to whether in the past year a doctor ever told them they had any of the above
medical conditions. Age groups include 65 – 69, 70 – 74, 75 – 79, 80 – 84 and 85+. We
categorized race into White, Black, Hispanics and others (American Indian, Asian or
Pacific Islander, etc.). Other variables included in our analysis were marital status
(married, widowed, divorced/separated, and other), education (Less than high school,
High school and College certificates), income level (Less than $15,000, $15,001 - $25,
000, and more than $25, 000), and insurance coverage (Medicare only, Both Medicare
and Employer-sponsored insurance (ESI), Both Medicare and Self-purchased).
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Defining Markov state
The Markov transition model is a stochastic modeling process [187, 188]. The
Markov process refers to subjects in a hypothetical cohort with a health condition moving
between different health states over time (time dependent Markov process) [189]. We
divided depression and BPH into distinctive and mutually exclusive states and assigned
transition probabilities for moving between states over a period. The Markov process for
depression were: no-depression in both years, moving from no-depression state in
previous year to depression in current year, depression in previous year to no-depression
in current year, and persistent depression for both years (Figure 1). Similarly, we defined
BPH Markov processes as no-BPH in both years, move from no-BPH state in previous
year to BPH in current year, move from BPH in previous year to no-BPH in current year,
and persistent BPH for both years (Figure 2).
Factors that could influence the transitions states include patients receiving any
treatment for depression or BPH (surgical or medical treatment for BPH) during the study
period, adherence to treatment, duration of treatment and other unknown factors.
Transition times
The first transition time was from baseline to the first follow up year, and the
second transition started from the end of first transition to the second year of follow-up.
In total, the subjects were followed for two years.
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Depression time 2
+
- No depression in both years No depression to depression
(Tpd1)
(Tpd2)
Depression time 1
+ Depression to no depression
Persistent depression
(Tpd3)
(Tpd4)
Tpd1 = transition probability no depression in both years
Tpd2 = transition probability from no depression to depression
Tpd3 = transition probability from depression to no depression
Tpd4 = transition probability of persistent
Figure 1. Markov process for depression progression.

BPH time 2
+
- No BPH in both years No BPH to BPH
(Tpb1)
(Tpb2)
BPH time 1
+
BPH to no BPH
persistent BPH
(Tpb3)
(Tpb4)
Tpb1 = transition probability no BPH in both years
Tpb2 = transition probability from no BPH to BPH
Tpb3 = transition probability from BPH to no BPH
Tpb4 = transition probability persistent BPH
Figure 2. Markov process for BPH progression.

Statistical analysis
We linked MCBS interview data with the Medicare claims from 2005 to 2009
using the base identification numbers. Our analysis was restricted to community dwelling
elderly men ages 65 years or above and also being followed up for at least one year. The
following were excluded hierarchically from our analysis: cases with prostate cancer
(n=133) and end-stage renal disease (n = 5). Descriptive statistics were performed for the
overall study population at the baseline using the SURVEYFREQ procedure in SAS. The
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proportions of Markov health states for depression and BPH by transition times were
estimated.
Generalized linear mixed models were used to estimate the instantaneous
likelihood of transition (Adjusted transition rates (ATR)), with covariance matrix
estimated by generalized estimating equations to explain the variation between repeated
measures (PROC GENMOD in SAS). We accounted for the complex sampling design by
incorporating the multilevel clusters and survey weight variables into all the analysis. All
analyses was done using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
At baseline, there were 5,807 elderly male beneficiaries who were eligible for the
study and followed for at least one year to determine the first transition probabilities. Of
them, 54% (n= 3138) were followed up for another year to determine the second
transition probabilities. The summary of baseline characteristics of the participants is
shown in table 7. The median age was 71. Nearly 9% (n=518) were depressed and 37%
had BPH at the start of the study. White males (88%) and married men (73%) were
majority in the study population.
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Table 7. Baseline summary of characteristics of study sample before transition.
Variables
Depressed
No
Yes
Benign prostatic hyperplasia
No
Yes
Race/Ethnicity
White Non-Hispanics
Black Non-Hispanics
Hispanics
Other
Age in years
65 – 69
70 – 74
75 – 79
80 – 84
85+
Marital status
Married
Widowed
Divorced/separated
Other
Education
Less than high school
High school
College
Income level
Less than $15,000
$15,000 - $25, 000
More than $25, 000
Comorbidity
Diabetes
Arthritis
Cancer
Heart disease
Mental Healthµ

N = 5, 807

Weighted percentage

5, 289
518

91.4
8.6

3, 615
2, 192

63.5
36.5

5, 135
393
125
154

88.1
7.2
1.9
2.8

1, 534
1, 251
1, 260
1, 0.95
667

31.8
23.4
21.7
14.6
8.4

4, 204
917
518
168

73.3
14.1
9.6
3.1

1, 539
1, 863
2, 405

25.0
32.5
42.6

463
1, 852
3, 492

7.6
30.4
62.0

1, 397
157
1, 647
2, 949
477

23.9
2.6
26.8
50.3
8.1
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Table 7 (Continued). Baseline summary of characteristics of
study sample before transition.
Variables
N = 5, 807 Weighted percentage
Insurance coverage
Medicare only
1, 941
33.8
a
ESI
2, 028
35.0
SPb
1, 381
23.0
c
ESI and SP
457
8.2
Total Comorbidities
0
1, 625
29.4
1
2, 341
39.8
2 or more
1, 841
30.9
a
Employer Sponsored Insurance (ESI) and Medicare
b
Self-purchased (SP) insurance and Medicare
c
Employer sponsored, self-purchased and Medicare insurance

The proportion with college education was 43% and 62% had income levels of
greater than $25, 000. Heart diseases including myocardial infarction, heart valve
diseases etc. are the most common medical conditions, followed by cancer. Elderly men
with Medicare only insurance accounted for about 34% (n=1,941) of the study sample.
The proportion of different depression and BPH states in two-transition time
points are shown in tables 8. Approximately 86% remained free of depression in the two
transition times, 5% moved from non-depression to depression state, and a similar
percent from depression to no depression, and about 4% had depression at both time
points. In addition, about 51% remained in no BPH health state for both time points and
11-12% moved from no BPH to BPH state, and 12% from BPH to no BPH and about
26% had BPH in both time points (Table 8).
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Table 8. Summary of BPH and depression status by Transition time points
Transition time
1
2
N=5, 807
N= 3, 138
n (%)
n (%)

Variables
Depression statesa
No depression in both years
4, 968 (85.8)
No depression to depression
321 (5.5)
Depression to no depression
293 (5.1)
Persistent depression
225 (3.7)
b
Benign prostatic hyperplasia states
No BPH in both years
2, 894 (50.7)
No BPH to BPH
721 (12.1)
BPH to no BPH
698 (11.6)
Persistent BPH
1514 (25.5)
a
Depression Markov states
b
Benign prostatic hyperplasia (BPH) Markov states

2, 708 (86.7)
171 (5.3)
142 (4.3)
117 (3.7)
1, 555 (50.7)
341 (10.7)
376 (11.9)
866 (26.7)

Transition probability matrix for the relation of depression and BPH is
summarized in table 9. At the first transition time, 87% of men who remained no BPH
health status also were in no depression state, while 5% of them moved in to depression
status. In contrast, 5.8% of those who moved from no BPH in previous year to BPH in
current year also moved from no depression to depression. Among those who moved
from BPH in previous year to no BPH, 6.7% also moved from depression to no
depression (Table 9). Results of the second transition matrix are similar. The proportion
persons who moved from no BPH to BPH state had about 6% chances of transiting from
no-depression to depression state.
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Table 9. Transition probability matrix for depression and benign prostatic hyperplasia
(BPH) relation

BPHa states
No BPH in both years
No BPH to BPH
BPH to no BPH
Persistent BPH

Depression states
No depression in No depression to Depression to no
both years
depression
depression
First transition time (N=5, 807)
n (%)
n (%)
n (%)
2, 516 (87.2)
158 (5.3)
128 (4.4)
599 (83.5)
44 (5.8)
39 (5.3)
582 (85.5)
30 (4.8)
45 (6.7)
1, 271 (84.1)
89 (5.8)
81 (5.5)

Second transition time (N = 3, 138)
No BPH in both years
1, 356 (87.6)
83 (5.1)
No BPH to BPH
298 (86.6)
20 (6.8)
BPH to no BPH
315 (83.8)
23 (6.0)
Persistent BPH
739 (86.4)
45 (4.9)
a
Benign prostatic hyperplasia

66 (4.0)
12 (3.5)
18 (4.7)
46 (4.8)

Persistent
depression
n (%)
92 (3.1)
39 (5.3)
21 (3.0)
73 (4.6)

50 (3.3)
11 (3.1)
20 (5.5)
36 (3.9)

Results from the multivariate analysis (Table 10) show that depression transition
status is generally consistent with BPH transition status. In particular, the likelihood of
moving from BPH to no BPH is significantly associated with moving from depression to
no depression than remaining in no-depression state (ATR, 1.49; 95% CI, 1.05-2.12;pvalue = 0.025). For those with persistent BPH, the transition probabilities of depression
appears independent of BPH status, and persistent depression also appears independent of
BPH status. The other significant factors that influenced the transition states of
depression in elderly men were age group, marital status, education and number of
comorbidities. We found that being a widower compared to being married significantly
changes depression status. Age groups of 70 years and above compared to 65 to 69 are
less likely to affect the transition processes of depression. In addition, the transition of
depression is lower in those with education levels of high school and above compared to
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less than high school, and income levels of more than $ 25, 000 compared to less than
$25, 000. Having two or more comorbidities compared to no comorbidity increased the
rate of transition from no depression to depression by about two fold (ATR, 2.16; 95% CI
1.67-2.81; p-value=0.021) and to persistent depression by 2.5 fold (ATR, 2.55; 95% CI,
1.78-3.66; p-value < 0.0001). Similar findings were observed in the analysis of the
second transition time but no significant association was found between BPH status and
depression status (Table 11).
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Table 10. Estimation of forward and backwards rates for depression in the first transition
time: Results from multivariate models

Variables
BPHc states
No BPH in both years (Ref)
No BPH to BPH
BPH to no BPH
Persistent BPH
Race/Ethnicity
White Non-Hispanics (Ref)
Black Non-Hispanics
Hispanics
Other
Age in years
65 – 69 (Ref)
70 – 74
75 – 79
80 – 84
85+
Marital status
Married (Ref)
Widowed
Divorced/separated
Other
Education
Less than high school (Ref)
High school
College
Income level
Less than $15,000 (Ref)
$15,000 - $25, 000
More than $25, 000

No depression to
depression
ATRb (95% CI)

Depression statea
Depression to
no depression
ATR (95% CI)

Persistent
depression
ATR (95% CI)

1.03 (0.74 – 1.44)
0.93 (0.62 – 1.39)
1.15 (0.88 – 1.51)

1.26 (0.88 – 1.82)
1.49 (1.05 – 2.12)
1.37 (1.02 – 1.83)

1.63 (1.12 – 2.38)
1.05 (0.65 – 1.68)
1.52 (1.11 – 2.09)

0.91 (0.59 – 1.41)
1.29 (0.71 – 2.34)
0.82 (0.39 – 1.74)

0.98 (0.62 – 1.55)
1.39 (0.74 – 2.62)
1.03 (0.48 – 2.19)

0.71 (0.42 – 1.18)
1.16 (0.53 – 2.57)
0.52 (0.19 – 1.40)

0.63 (0.45 – 0.89)
0.98 (0.71 – 1.36)
0.75 (0.52 – 1.07)
0.91 (0.62 – 1.34)

0.86 (0.60 – 1.22)
1.03 (0.72 – 1.48)
0.73 (0.50 – 1.08)
0.86 (0.56 – 1.32)

0.59 (0.40 – 0.90)
0.74 (0.50 – 1.10)
0.59 (0.39 – 0.91)
0.87 (0.57 – 1.33)

1.46 (1.10 – 1.95)
1.40 (0.99 – 1.99)
0.47 (0.18 – 1.23)

1.71 (1.26 – 2.33)
1.94 (1.37 – 2.74)
0.87 (0.40 – 1.88)

1.77 (1.29 – 2.43)
1.18 (0.76 – 1.81)
1.42 (0.70 – 2.86)

0.77 (0.59 – 1.02)
0.80 (0.60 – 1.06)

0.94 (0.70 – 1.26)
0.76 (0.55 – 1.05)

0.74 (0.53 – 1.01)
0.64 (0.45 – 0.89)

1.06 (0.71 – 1.57)
0.60 (0.40 – 0.92)

1.03 (0.68 – 1.56)
0.68 (0.44 – 1.07)

0.92 (0.59 – 1.43)
0.53 (0.33 – 0.86)
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Table 10 (Continued). Estimation of forward and backwards rates for depression in the first
transition time: Results from multivariate models.

No depression to
depression
ATRb (95% CI)

Depression statea
Depression to
no depression
ATR (95% CI)

Variables
Insurance coverage
Medicare only (Ref)
d
ESI
1.07 (0.82 – 1.40) 1.13 (0.84 – 1.54)
SPe
0.88 (0.65 – 1.21) 0.99 (0.72 – 1.37)
f
ESI and SP
1.44 (0.96 – 2.18) 1.27 (0.79 – 2.06)
Total Comorbidities
0 (Ref)
1
1.27 (0.93 – 1.74) 0.94 (0.69 – 1.28)
2 or more
2.22 (1.64 – 3.00) 1.42 (1.06 – 1.91)
a
Depression states: Ref = 0 (No depression in both years)
b
Adjusted transition rate
c
Benign prostatic hyperplasia
d
Employer Sponsored Insurance (ESI) and Medicare
e
Self-purchased (SP) insurance and Medicare
f
Employer sponsored, self-purchased and Medicare insurance
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Persistent
depression
ATR (95% CI)
1.03 (0.74 – 1.45)
1.11 (0.78 – 1.57)
0.91 (0.49 – 1.67)
0.94 (0.63 – 1.42)
2.55 (1.78 – 3.66)

Table 11: Estimation of forward and backwards rates for depression in the second
transition time: Results from multivariate models.
No depression to
depression
ATRb (95% CI)

Depression statea
Depression to
no depression
ATR (95% CI)

Variables
BPHc states
No BPH in both years (Ref)
No BPH to BPH
1.25 (0.76 – 2.04) 0.94 (0.53 – 1.67)
BPH to no BPH
1.20 (0.76 – 1.89) 1.30 (0.79 – 2.16)
Persistent BPH
0.95 (0.67 – 1.36) 1.14 (0.78 – 1.65)
a
Depression states: Ref = 0 (No depression in both years)
b
Adjusted transition rate
c
Benign prostatic hyperplasia

Persistent
depression
ATR (95% CI)
1.10 (0.59 – 2.03)
1.78 (0.58 – 2.98)
1.31 (0.86 – 2.01)

Discussion
The present study used data from a dynamic cohort of a nationally representative
sample of elderly men in the US to explore the transition probabilities of depression and
BPH in elderly male Medicare beneficiaries. We examined depression and BPH status in
two transition times over two follow up years. This is the first study that examined the
progression of depression and BPH in elderly men using the time dependent Markov
model. The Markov modeling technique is a natural modeling process with minimal
assumptions. This is the most important strength of our study. The main advantages of
using the transitional model, compared with other traditional model such as logistic
regression and survival analysis, are that it allows the flexibility to explore all possible
combinations of outcomes/exposures changing status, which is not possible in the
traditional modeling.
A second strength of our study is that our study population was drawn from a
National representative sample of the US elderly population using linked data from
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MCBS health survey and Medicare claims. Thirdly, the time order in our study provides
opportunities to assess cause and effect in the relation of BPH and depression.
Our results show that BPH status significantly influences the progression of
depression in elderly men. For instance, our results show that moving from BPH to noBPH significantly increases the transition rate from depressed to non-depressed states in
elderly men, and having persistent BPH compared remaining with no-BPH health
condition is associated with about 40% increased risk of moving to persistent depression
than remaining is no-depression state. Huang et al, (2011) used survival analysis to
examine the risk of depression in men with BPH compared to those with no BPH after
one year follow up. Their results suggest that having BPH compared to the no BPH
increased the risk of developing depression in one year among elderly Chinese population
[125]. Similarly, the results from our study show that moving from no-BPH to BPH
health state increases the transition rate from no-depression to depression state though not
statistically significantly. In addition, we observed that having one or more comorbidity
significantly increased the risk of transiting from non-depressed to depressed state by two
folds. This supports findings of significant association of depression and medical
conditions such as heart diseases, cancer, and diabetes in the elderly as noted in other
studies [142, 146, 160, 161, 190-196].
In addition to BPH and comorbidity, our study revealed that marital status and
high education significantly influence the progression of depression in elderly men.
Notably, widowed or divorced/separated elderly men compared with married are
associated with increased risk of change of depression status. Bereavements or loss of
loved ones are common adverse events found among aging people and have been shown

46

to be significantly associated with depression in the elderly. For the elderly population,
marriage plays a pivotal role compared to other forms of social relationship. Studies show
that married individuals are more likely to have happier, life satisfaction and lower risk of
depression to non-married status [197-199]. Furthermore, it has been suggested that being
married is associated with healthier mental health state in the aging population [199].
Similar to other studies, our findings revealed the importance of the protective effect of
higher education levels. We observed that elderly men with high school or college level
education compared with less than high school levels are less likely to transit from nodepression state to depression state. In addition, those with high school or college levels
education compared with those with less than high school education are less likely to
transit from non-depressed to depressed state, and less likely to remain in persistent
depression state [200].
This study is not without limitations. An important limitation of Markov model is
the “memoryless” of process, i.e., the probability of moving in or out is independent of
the state that the patients may have experienced before entering that state [187].
Secondly, the sensitivity of depression screening instrument in the MCBS questionnaire
is unknown. We combined the clinically diagnosed codes from the claim data with survey
questions to minimize this problem. The third limitation of this study is that we did not
control for factors such as treatments types, adherence and duration of diseases that may
influence the change of either depression or BPH states. Nevertheless, this study provides
critical information for future investigations on the time order between BPH and
depression in both clinical and population settings.
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Conclusion
This study estimates the transition probabilities of depression and BPH
state changes in elderly men. Results from this study indicate that transition from BPH to
non-BPH states is associated with transition from depressed to non-depressed state.
Presence of two or more coexisting medical conditions increases the progression to
depression by two folds. These findings suggest that prompt corrective interventions in
the management of BPH in elderly men may significantly reduce the progression of
depression in this population.
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CHAPTER 4
EFFECTS OF RACE AND SOCIOECONOMIC DISADVANTAGE ON
DEPRESSION IN ELDERLY MEN WITH BENIGN PROSTATIC
HYPERPLASIA
Introduction
Previous studies suggest that social and economic differences are major factors
that influence health outcomes [201-203]. Race/ethnicity and income level are two key
indicators of socioeconomic disadvantage in the United States [204]. Research on chronic
medical morbidities suggests significant relationships between race/ethnicity and
socioeconomic status (SES), and health outcome [204-207]. Depression, like many other
medical conditions, disproportionately affects populations with lower SES and minority
groups [208]. A study of the US population drawn from the National Health and
Nutrition Examination Survey (NHANES) demonstrates that living below poverty level
increases the risk of major depressive disorder by 1.5 folds [209]. Even though minority
status such as being a Hispanic or African American is not exclusively related to lower
SES, the largest groups of minority citizens in the United States are found in lower SES
brackets [210, 211].
The mechanisms through which ethnicity and socioeconomic status may account
for the differences in health outcomes include genetic predisposition, coping skills,
deprivation of resources, discrimination, unequal access to health care and quality of
health care [211, 212]. Studies have proposed cumulative advantage theory as an
alternative explanation for the effect of SES on health outcomes [213-216]. For instance,
individuals with higher SES indices such as higher education and income level have
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cumulative resources that enhance their ability to avoid chronic stressors and to live a
healthier lifestyle. Higher SES including higher income level is associated with more
happiness and self-confidence while lower income is associated with greater vulnerability
to mental health disorder [206]. Further, lower income status has been connected with
more challenging experiences and emotional distresses such as feelings of hopelessness,
depression, and life dissatisfaction [211]. With the increasing aging population in the
United States and elsewhere, the impact of socioeconomic disadvantage on the quality of
health is a major concern [1, 217-219]. Some studies suggest that inequality in risk of
mental health conditions observed in the elderly population may be due to differences in
SES [220-222].
Depressive disorders account for a significant proportion of mental health illness
among the elderly in the United States [223]. The association between depression and
chronic medical conditions has been well studied [224-228]. Recently, some studies that
examined the effect of benign prostatic hyperplasia (BPH) on depression in aging men
observed a higher risk of depression in those with BPH compared to those without BPH
[108, 125, 126, 128-130, 224]. BPH is benign growth of the prostate gland that develops
with aging in men. It is the most common cause of bothersome lower urinary tract
symptoms (LUTS) such as urinary frequency, bladder outlet obstruction, nocturnal
urination, and straining elderly men [99, 229-231]. Although, results from these studies
suggest a relation between BPH and depression, this finding might not be directly linked
to the effect of BPH, rather the relationship may be due to heterogeneity in social and
economic context of the population of men with BPH.
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The objective of the study was to evaluate the influence of social and economic
disadvantage on association of depression in elderly men with BPH. We hypothesized
that the risk of depression is higher among the minority group with BPH compared to the
White elderly men with BPH, and higher among lower income groups compared to
higher income group. This study used a combined five-year data from Medicare Current
Beneficiary Survey (MCBS) report and the Medicare claims data.
Materials and methods
Study population
The study population was drawn from a nationally representative sample of
elderly Medicare beneficiaries who participated in the health survey from 2005 through
2009. The study sample comprised of only community dwelling elderly men aged 65
years or above, who were identified as having benign prostatic hyperplasia either
reported in the MCBS survey or clinically diagnosed in the claims data using the
International Classification of Diseases Ninth edition (ICD 9) codes. The MCBS data is a
de-identified, continuous multipurpose survey of nationally representative sample of the
Medicare population including both aged and disabled enrollees conducted by the
Centers for Medicare & Medicaid Service [232].
The MCBS Cost and Use File links personal interview data and Medicare claims
for each survey year longitudinally. Medicare claims data include inpatient, outpatient,
and physician/supplier services claims that provide additional information on the
diagnosis, procedures, and cost for all the Medicare reimbursed services for the survey
year. Each Participant in the MCBS survey completed questionnaires to provide
demographic information including age, race, education level, annual income, marital
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status, and medical conditions including BPH, depression, cancer, arthritis, heart diseases
etc. In addition, we identified clinically diagnosed cases of depression and BPH using
the International Classification of Disease, 9th edition Clinical Modification (ICD-9-CM
reported in the Medicare claims data. For benign prostatic hyperplasia (BPH): We
identified the main independent variable (BPH) from responses to the question on
whether “Past year respondent was told he had enlarged prostate/BPH” (“yes” or “no”).
The ICD-9-CM codes according to Urologic disease in America’s recommendation for
BPH were 594.1 (Other calculus in bladder), 599.6 (Urinary obstruction), 599.60
(Urinary obstruction, unspecified), 600 (hyperplasia of the prostrate), 788.2 (Retention of
urine), and 788.4 (Frequency of urination and polyuria) [233, 234].
We excluded those with history of prostate cancer and those with renal failure.
The final sample included 4,578 elderly men with BPH.
Measures
Outcome Measure
Depression: The survey questionnaire had two depression questions. The first
question was whether the respondent was sad or depressed in the past 12 months (“all of
the time”, “most of the time”, “some of the time”, “a little of the time” and “none of the
time”. The second question was whether they had loss of interest in the past 12 months
(‘yes” or “no”). Based on the survey responses, we defined depression using two criteria:
(1) Any respondent who reported sad or depressed “all of the time” or “most of the time”
and (2) sad or depressed “some of the time” and loss of interest. The third definition of
depression was based on the International Classification of Disease, ninth edition Clinical
Modification (ICD-9-CM) codes reported in the claims data. The depression codes, based
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on prior studies, include 296.2 (major depressive disorder, single episodes), 296.3 (major
depressive disorder, recurrent episodes), 300.4 (neurotic depression), 309.0 (Adjustment
disorder with depressed mood), 309.1 (prolonged depressive reaction), and 311
(depression, not elsewhere classified).[79, 235] The self-reported depression and the
clinically diagnosed depression were then combined. We coded depression as a binary
variable (yes or no).
Socioeconomic indicators
The main socioeconomic indicators in our analysis are race and income level.
Other indicators include education, marital status, and health insurance. We categorized
the variables as follows: Education (Less than high school, High school and College
certificates). Income level (Less than $15,000, $15,001 - $25, 000, and More than $25,
000), and Insurance coverage (Private only, Medicare only, Self-purchased (SP) and
Medicare, Employer sponsored Insurance (ESI) and Medicare, and Both SP/ ESI and
Medicare). Other independent variables consist of demographic characteristics (age (65 –
69, 70 – 74, 75 – 79, 80 – 84 and 85+), race (White, Black, and Hispanics), Marital status
(Married, Widowed, Divorced/separated, and other).
Statistical analysis
We combined all cases of reported BPH from the MCBS survey and Medicare
claims data over five years period (2005 to 2009). The period prevalence was estimated
and Chi-squared test was used to compare the socioeconomic characteristics. We applied
the yearly weight and multilayer cluster in all our analysis. We used the SAS
SURVEYFREQ procedure to calculate the proportions and weighted percentages. The
adjusted risk ratio of depression was estimated using the generalized estimation equation
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(GEE) method. We selected our final model using the quasi-likelihood information
criteria (QIC) fit statistics, which states that the smaller is best fit. All data processing and
statistical analysis was done using the SAS software version 9.4 (SAS Inc., Cary, NC).
Results
During the five years survey period, 4,578 elderly Medicare beneficiaries reported
having BPH. Of them, 727 (16%) had depression. Table 12 shows the distribution of
social and economic characteristics of beneficiaries with BPH. A majority of our sample
population were Whites (89%, n=4,087) and married men (72%, n = 3,300). About 46%
(n = 2, 090) of the total respondents had college education level, and 2,845 (62%) had
annual income level of greater than $25, 000. Approximately 74% (n= 3, 395) of the
beneficiaries had either additional self-purchased insurance, employer sponsored
insurance or both.
Results from our multivariate analysis of socioeconomic predictors of depression
in the elderly with BPH are shown in table 13. We found no significant association of
race and risk of depression in elderly with BPH. Age groups 70 years and above
compared with 65 to 69 years had significantly higher risk of depression. The risk of
depression was 50% higher in widowed men with BPH (ARR, 1.50; 95% CI, 1.26-1.80),
and 33% higher in divorced men with BPH (ARR, 1.33; 95%CI, 1.06-1.68). In contrast,
compared to less than high school, the risk of depression in men with BPH was lower in
educational levels of high school (ARR, 0.87; 95% CI, 0.72-1.04) or college (ARR, 0.71;
95% CI 0.59-0.85). No significant difference in the risk of depression was seen among
the types of insurance coverage.
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Table 12. Distribution of social and economic characteristics of elderly men with BPH
by depression status.
Depressed, N=727 Not depressed, N= 3, 821
Variables
n (weighted %)
n (weighted %)
Race/Ethnicity
White
644 (88.2)
3, 443 (89.4)
Black
49 (7.5)
218 (6.3)
Other
34 (4.3)
160 (4.3)
Age in years
65 – 69
92 (14.7)
640 (23.4)
70 – 74
143 (22.7)
879 (24.5)
75 – 79
178 (26.6)
790 (21.4)
80 – 84
154 (17.8)
835 (17.5)
85 +
160 (18.2)
677 (13.2)
Marital status
Married
453 (62.4)
2, 847 (75.7)
Widowed
180 (23.3)
586 (13.5)
Divorced/ Separated
75 (10.7)
284 (7.8)
Other
19 (3.6)
104 (3.0)
Education
Less than high school
242 (31.7)
864 (21.7)
High school
223 (31.1)
1, 132 (28.9)
College
262 (36.2)
1, 825 (49.5)
Income level
Less than $15,000
72 (9.7)
230 (5.8)
$15,000 - $25, 000
292 (39.7)
1, 109 (28.3)
More than $25, 000
363 (50.6)
2, 482 (65.8)
Insurance coverage
Medicare only
219 (30.3)
964 (26.2)
ESIa
271 (37.7)
1, 481 (38.9)
SPb
183 (24.6)
996 (25.2)
c
Both ESI and SP
54 (7.4)
380 (9.7)
a
Employer Sponsored Insurance (ESI) and Medicare
b
Self-purchased (SP) insurance and Medicare
c
Employer sponsored, self-purchased and Medicare insurance
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Table 13. Multivariate analysis of socioeconomic determinants of depression among
elderly men with benign prostatic hyperplasia.
Variables
ARRa
95% CI
Race/Ethnicity
White (Ref)
Black
0.93
0.69 – 1.26
Other
0.81
0.55 – 1.18
Age in years
65 – 69 (Ref)
70 – 74
1.34
1.01 – 1.80**
75 – 79
1.68
1.28 – 2.19**
80 – 84
1.38
1.03 – 1.85**
85 +
1.60
1.20 – 2.14**
Marital status
Married (Ref)
Widowed
1.50
1.26 – 1.80**
Divorced/ Separated
1.33
1.06 – 1.68**
Other
1.28
0.76 – 2.16
Education
Less than high school (Ref)
High school
0.87
0.72 – 1.04
College
0.71
0.59 – 0.85**
Income level
Less than $15,000 (Ref)
$15,000 - $25, 000
0.87
0.68 – 1.11
More than $25, 000
0.63
0.48 – 0.83**
Insurance coverage
Medicare only (Ref)
b
ESI
1.09
0.91 – 1.31
SPc
1.00
0.81 – 1.23
Both ESI and SPd
0.95
0.70 –1.27
a
Adjusted risk ratio
b
Employer Sponsored Insurance (ESI) and Medicare
c
Self-purchased (SP) insurance and Medicare
d
Employer sponsored, self-purchased and Medicare
insurance
** Significant level with p-value < 0.05
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We further stratified the analysis by race (Table 14). The result showed that
among White elderly with BPH, the risk of depression was significantly higher among
the widowed compared to the married men (ARR, 1.61; 95% CI, 1.33-1.95). Compared
to White men with income of less than $15,000, the risk of depression was lower among
Whites with income of greater than $25,000 (ARR, 0.62; 95% CI, 0.45-0.84). Whites
with college level education had lower risk of depression than those with less than high
school education (ARR, 0.68; 95% CI, 0.56-0.83). Similarly, among the Blacks, those
income levels of greater than $25, 000 compared with less than $15,000 had significantly
lower risk of depression (ARR, 0.18; 95% CI, 0.07-0.50).

Table 14. Multivariate analysis of socioeconomic determinants of depression among
elderly men with benign prostatic hyperplasia comparing White and Black races.
White, N = 4, 087
Blacks, N = 267
Variables
ARR* (95% CI)
ARR (95% CI)
Marital status
Married (Ref)
Widowed
1.61 (1.33 – 1.95)**
1.06 (0.60 – 1.88)
Divorced/ Separated
1.27 (0.99 – 1.64)
1.43 (0.71 – 2.90)
Other
1.30 (0.75 – 2.28)
1.23 (0.35 – 4.33)
Education
Less than high school (Ref)
High school
0.87 (0.71 – 1.05)
1.22 (0.61 – 2.42)
College
0.68 (0.56 – 0.83)**
1.59 (0.80 – 3.19)
Income level
Less than $15,000 (Ref)
$15,000 - $25, 000
0.83 (0.63 – 1.10)
0.55 (0.28 – 1.08)
More than $25, 000
0.62 (0.45 – 0.84)** 0.18 (0.07 – 0.50)**
Note: Model was adjusted risk ratio and 95% confidence intervals were
adjusted for age group, marital status, education, income level and
insurance coverage. The reference for depression is no depression
** Significant level with p-value < 0.05
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Table 15 shows the adjusted risk ratio and 95% confidence intervals stratified by
income level. We found that showed that elderly in Other race groups (including
Hispanics) with income level of less than $15,000 compared to White group had a
significantly lower risk of depression (ARR, 0.29; 95% CI, 0.12-0.71). Among elderly
with income levels between $15,000 and $25,000, widowed were about 58% at higher
risk of depression compared to the married with BPH (ARR, 1.58; 95% CI, 1.22-2.05),
while those with college level education compared to less than high school education had
significantly lower risk of depression (ARR, 0.63, 95% CI, 0.45-0.87). Widowed elderly
men with BPH who had annual income of greater than $25,000 were more likely to
depressed than those who were married (ARR, 1.52; 95% CI, 1.15-2.01). However, those
annual income of greater than $25,000 and college level education were at lower risk of
depression than those with less than high school and income of $25,000 (ARR, 0.73, 95%
CI, 0.55-0.97).
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Table 15. Multivariate analysis of determinants of depression in elderly men with benign prostatic hyperplasia
comparing income levels.
< $15, 000
N = 302
ARRa (95% CI)

Income groups
$15, 000 - $25, 000
N = 1, 401
ARR (95% CI)

>$25, 000
N = 2, 845
ARR (95% CI)

Variables
Race/Ethnicity
White (Ref)
Black
1.26 (0.79 – 1.99)
0.91 (0.62 – 1.33)
0.60 (0.26 – 1.35)
Other
0.29 (0.12 – 0.71)**
0.93 (0.61 – 1.42)
1.35 (0.71 – 2.56)
Marital status
Married (Ref)
Widowed
1.02 (0.58 – 1.80)
1.58 (1.22 – 2.05)** 1.52 (1.15 – 2.01)**
Divorced/ Separated
1.21 (0.70 – 2.08)
1.13 (0.78 – 1.63)
1.42 (0.88 – 2.30)
Other
0.96 (0.43 – 2.15)
1.06 (0.52 – 2.17)
1.46 (0.57 – 3.72)
Education
Less than high school (Ref)
High school
0.58 (0.31 – 1.11)
0.86 (0.68 – 1.09)
0.93 (0.67 – 1.29)
College
1.12 (0.67 – 1.87)
0.63 (0.45 – 0.87)** 0.73 (0.55 – 0.97)**
Note: Model was adjusted risk ratio and 95% confidence intervals were adjusted for age group,
race, marital status, education, and insurance coverage. The reference for depression is no
depression
** Significant level with p-value < 0.05
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Discussion
This study used a combined five years from the Medicare Current Beneficiary
Survey and claims data to examine the influence of social and economic heterogeneity on
depression in elderly men with BPH. Overall, the prevalence of depression in elderly men
with BPH was approximately 16%, which was higher than that reported among
community dwelling elderly (5%) and primary care setting (10%) in the United States [4,
15, 137, 138]. The results from our study showed an association between marital status,
education and income levels and the risk of depression in elderly men with BPH. This
was the first study that examined the effect of socioeconomic disadvantage on depression
among elderly men with BPH. Although there was no statistical evidence of effect of race
on depression in men with BPH, our findings suggests that even within same racial
groups there may be differential effects of social and economic factors on depression.
Similar associations have been reported in other studies that considered effect of
socioeconomic factors on depression within racial/ethnic strata [25, 77, 204, 205, 209,
211].
Result from our study suggest that elderly White men with BPH and high income
levels had lower risk of depression compared to the those in lower income levels. Riolo et
al, 2005, reported similar findings in their study population drawn from the NHANES III
survey. They found a significant association between poverty and major depressive
disorders among Whites respondents [77]. Our findings may be explained by stressful
effects of daily living experiences of lower income groups, coupled with the bothersome
and psychological distresses associated with LUTS in aging men. Drawing from the
cumulative disadvantage/advantage theory, income level may be an important factor that
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determines the risk of developing depression in men with BPH during late life. The
theory of cumulative disadvantage highlights ways an early social and economic
advantage or disadvantage may differentiate a population’s health trajectory over time
[214-216, 236]. Inequality in access to care is a common consequence of socioeconomic
disadvantage. For instance, individuals who cannot afford adequate health insurance are
faced with limited health care choices. Other studies suggest that inadequate access to
healthcare, more common among person with low income and minority, was an
important prognostic factor for poor health outcomes [237-241]. Further, we observed
that within the high-income group, those with higher education levels are significantly at
lower risk of depression compared to those with low education levels.
Other studies have reported a significant effect of marital status on depression in
the elderly population [242-246]. It has been shown that widowhood or divorced marital
status compared to married significantly increased the risk of depression especially in the
older population. Our study also observed a similar relationship between marital status
and depression in men with BPH. We observed that elderly widowed or divorced with
BPH were at higher risk of depression compared to elderly married men with BPH.
Further, among White men with BPH, the risk of depression was significantly higher in
the widowed compared to the married elderly men. These findings suggest that loneliness
and social isolation may influence depression in elderly men with BPH. A study by
Alpass and Neville, 2003, demonstrated that a significant relationship exist between
loneliness and psychological wellbeing of older males. They found that loneliness was
the most significant factor associated with higher Geriatric Depression Scale score (GDS)
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in their study population [247]. Another study also showed a 10-20% risk of developing
depressive symptoms with the first years of bereavement [23].
One of the main strength of our study was that our study population was drawn
from a national representative sample of elderly men with BPH in the United States.
Secondly, we defined depression and BPH using both clinical (ICD-9 codes from claims
data) and self-report (MCBS survey) information. However, our study has several
limitations. This was a cross sectional study and therefore we could not ascertain
causality in this association. A longitudinal study would be more suitable to determine
the cumulative effect of “life-time view” of the social and economic factors on
depression in elderly men starting from middle life. This will extend our understanding of
whether cumulative disadvantage, with focus on socioeconomic heterogeneity, may
explain the relationship between depression and BPH in elderly men. Secondly, our study
sample was underpowered to detect effects of others on depression due to small sample
size and majority were Whites with BPH. Thirdly, we did not have enough sample size to
compare the differences in risk of depression between White elderly males with BPH and
other races including Hispanics with BPH.
Conclusion
The findings from this study provide additional data to support the influence of
socioeconomic context on the risk of depression in elderly men with BPH. Our data
suggests that socioeconomic disadvantages may exist in association of BPH and
depression in the elderly. Further epidemiologic research in a larger cohort is needed for
a better understand the effect of socioeconomic heterogeneity on depression in elderly
men with BPH. Social and economic cumulative advantage/disadvantage from early
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lifetime may be plausible explanation of the difference in the health trajectory of the
elderly population.
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CHAPTER 5
CONCLUSION
Dissertation summary
Depression in the elderly is common among those with chronic diseases including
cancer, diabetes, heart diseases and chronic obstructive airway diseases [1, 4, 23, 51, 69,
223]. Recently, several new reports suggested an effect of benign prostatic hyperplasia
(BPH) on depression among aging men [108, 125-129]. BPH, a common problem with
aging men, often presents with distressing lower urinary tract symptoms (such as frequent
urination at night, difficulty in passing urine), which negatively affects the quality of life
of elderly men [93-96, 98, 108, 125-129]. Studies that explored the association between
BPH and depression in men are limited [108, 125-127]. However, these studies suggest
that the risk of depression is higher among men with BPH or lower urinary tract
symptoms, compared to those with no BPH [108, 125-127].
There are several research questions unanswered in the relationship between
depression and elderly men and paucity of data remains an issue. We have tried to fill
some gaps:
1.

What is the prevalence of depression and BPH in elderly male Medicare

beneficiaries, aged 65 years or above, and what factors are associated with depression
reported among elderly male Medicare beneficiaries, 65 years or above, in the United
States?
2.

What is the rate of transition of elderly Medicare beneficiaries with no

depression state to depression state and how does BPH influence the transition states of
depression?

64

3.

Does socioeconomic disadvantage influence the occurrence of depression

in aging with BPH?
We hypothesized that the risk of depression was higher among elderly with BPH
compared to those without BPH. Our second hypothesis was that BPH influences the
transition states of depression. We also hypothesized that there was a significant effect of
socioeconomic disadvantage on depression in elderly men with benign prostatic
hyperplasia.
We conducted our study using the Medicare Current Beneficiary Survey (MCBS)
data and physicians’ claims data from 2005 through 2009. The MCBS is a nationally
representative data conducted by the Center for Medicare and Medicaid Services (CMS).
From the MCBS survey data, we defined depression from survey questionnaires as
follows: (1) Any respondent who reported sad or depressed “all of the time” or “most of
the time” and (2) sad or depressed “some of the time” and loss of interest. The third
definition of depression was based on the International Classification of Disease, ninth
edition Clinical Modification (ICD-9-CM) codes reported in the claims data. [38] BPH
was determined using the response to MCBS survey on whether “Past year respondent
was told he had enlarged prostate/BPH” (“yes” or “no”). Second instrument was the
clinically diagnosed BPH using the ICD-9-CM codes reported in the claims data. The
MCBS survey data also contained information on socio-demographic characteristics and
comorbidities including cancer other than skin cancer, arthritis, diabetes, heart diseases
and mental health diseases other than depression. To address our second research
question, we constructed transition time points using the year variable in the MCBS data.
In addition, we defined Markov state for depression (no depression in both years, no
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depression to depression, depression to no depression, and persistent depression states),
and BPH (no BPH for both years, no BPH to BPH, BPH to no BPH, and persistent BPH
states).Our third research question was addressed using the sample of only elderly men
with BPH.
The results showed a significantly higher risk of depression in elderly men with
BPH compared to those without BPH. Even among those without coexisting medical
conditions like cancer, diabetes, heart diseases, and arthritis, the risk of depression
increased by 70% in those with BPH compared to elderly with no BPH. Further, having
additional two or more comorbidities such as cancer, diabetes mellitus, and heart diseases
increased the risk of depression by two folds in elderly with BPH compared with no
BPH.
The second study revealed for the first time that the Markov process of depression
is significantly influenced by the health status of BPH in elderly men. We observed the
following in the transition analysis : 1) progressing from BPH to no-BPH Markov
process significantly increased the transition rate from depressed to non-depressed states
in elderly men, 2) having persistent BPH compared remaining with no-BPH is associated
with about 40% increased risk of moving to persistent depression than remaining is nodepression state. 3), moving from no-BPH to BPH health state increased the transition
rate from no-depression to depression state but not statistically significant. Our third
study demonstrated that elderly men with BPH and high-income or high-education levels
were at significantly lower risk of depression than those in the lower income group or
low education levels. Overall being married provided a protective effect for depression
than widowed or divorced/separated in the elderly male population.
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Strengths and limitations
The strengths of this dissertation research include: first, we used a cohort data
from the survey conducted in a large national representative sample of elderly men in the
United States. Second, definitions of the depression and BPH were done using both selfreported data and clinically confirmed diagnosis. The survey data was drawn from the
MCBS data conducted yearly among elderly Medicare beneficiaries from ages 65 years
or above, and among those with disability. The clinical information was obtained from
the Medicare claims database built for billing purpose. The third strength of our study
was using the Markov modelling approach to examine the relation between BPH status
and depression progression in our study population. The time order established in the
transition analysis may help establish a cause-effect relationship between BPH and
depression in this study population. Unlike survival analysis, the Markov’s modeling is a
natural modeling technique with minimal assumptions. Lastly, we adjusted for
characteristics like medical conditions (cancer, heart diseases, diabetes, arthritis and
cancer), and socio-demographic variables that may confound the association between
depression and BPH in elderly population.
The drawbacks of our study are: (1), our dataset was drawn from a short follow up
data therefore detecting developments or changes in the characteristics of the target
population at both the group and the individual level is difficult. (2) All our study
subjects had either Medicare insurance or other private insurance, so findings may not be
generalizable to the uninsured population of elderly men. (3) The racial distribution of the
study population is skewed with Whites being disproportionately more than other races.
This may have resulted in some of the findings observed in White elderly men with BPH.
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Except for Blacks with BPH, we were unable to compare effects of socioeconomic
heterogeneity between Whites men with BPH and other racial groups including
Hispanics. (4) Information about LUTS symptoms and depression was not provided.
Therefore, we could not assess the effect of severity of BPH on depression. (5) Several
factors would have influenced the Markov process in our study. For instance, we did not
control for factors such as whether the respondent was receiving treatment during the
follow-up period, the type of treatment and treatment adherence that may have influenced
progression of depression or BPH. (6) An important limitation of Markov model is the
“memoryless” feature of Markov process, i.e. the probability of moving out is
independent of the state the patients may have experienced before entering that state.
Lastly, the sensitivity of depression screening used in the MCBS questionnaire is
unknown.
Clinical implications and recommendations
Our findings have strong implications for clinical management of elderly men
with depression. Evidence supports that depression is often undetected or undertreated in
the clinics. In addition to chronic medical comorbidities in elderly men, the presence of
BPH may significantly increase the risk of depression in this population. Therefore,
elderly men with BPH should be carefully evaluated for depressive symptoms especially
in the primary care settings to reduce further disability from persistence of BPH and
depression. Findings from our transition analysis suggest that progressing from BPH
health state to state without BPH is significantly associated with transition from
depressed to non-depressed state. One of the possible explanations may be due to
treatments received during the study period. However, our study suggests that prompt
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corrective intervention for BPH symptoms may be needed to moderate the progression of
depression in elderly men.
Public health implication and recommendations
In recent years, reports have suggested a growing population of aging people both
in the US and elsewhere. This implies a possible rise in the prevalence of chronic
diseases such as depression, diabetes mellitus, heart diseases, cancer, arthritis and mental
health conditions. This dissertation addressed an important concern among aging men,
the relationship between BPH and depression in late life. More research is necessary to
understand the biological pathways and genetic explanation for the association of BPH
and risk of depression in elderly men. Several reports suggest that depression is
associated with disability and low health quality of life in the older population. Therefore,
we recommend that adequate research in this area is critical to mitigate the impact of
BPH and depression on the quality of life of the aging men.
Suggestions for future research
This is the first attempt that explored the transition probability of Markov
processes of depression and BPH in the population of US elderly men. We found that
BPH states as well as socioeconomic indices significantly influence the progression of
depression in elderly men. However, further research applying other epidemiological
methods and socioeconomic indices is needed to validate our findings in a different
population. In addition, epidemiologic research with a focus on cumulative
advantage/disadvantage from early lifetime should be considered to get a better
understanding of health trajectory in the elderly population. Lastly, future research could
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explore how the severity of lower urinary tract symptoms of BPH could affect the
transition in depression severity.
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GLOSSARY
Depression: is a mood disorder that causes a persistent feeling of sadness
and loss of interest.
Late life depression (LLD): First diagnosis of depression after 65 years old
Benign prostatic hyperplasia (BPH): Noncancerous-enlargement of the
prostate gland. Also referred to as benign prostatic enlargement
Lower urinary tract symptoms (LUTS): refers to symptoms due to
abnormality or compression of the ureters, urinary bladder and urethra resulting in
poor stream, hesitancy, terminal dribbling and incomplete voiding.
Chronic diseases: Medical conditions lasting for more than three months
Beneficiary: Refers to anyone enrolled in Medicare, regardless of use of
services
Chronic obstructive airway disease: Refer to a group of lung diseases that
block airflow and make breathing difficult. Examples are emphysema and chronic
bronchitis
Diabetes mellitus: A group of diseases that affect how the human body uses
glucose, commonly called blood sugar. This condition includes Type 1 and II
diabetes
Heart disease: is one of several cardiovascular diseases (diseases of the
heart and blood vessel system) affecting the heart. Other cardiovascular diseases
include stroke, high blood pressure, angina (chest pain), and rheumatic heart
disease.
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Osteoarthritis: degeneration of joint cartilage and the underlying bone. It is
commonly associated with aging. It causes pain and stiffness, especially in the hip,
knee, and thumb joints. Also referred to as arthritis
Cancer: Diseases characterized by the development of abnormal cells that
divide uncontrollably and have the ability to penetrate and destroy normal body
tissue.
Comorbidity: The presence of one or more additional disorders (or diseases)
co-occurring with a primary disease or disorder
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